Cupric Chloride Injection, Solution
NDC Package 51754-0103-4
Package Information
Cupric Chloride injection is uSP 0.4 mg/mL is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN). This formulation utilizes a injection, solution delivery system. Marketed by Exela Pharma Sciences, Llc, this product is identified by NDC 51754-0103 and is authorized under FDA application ANDA212071.
Identification & Billing
- RxCUI: 204536 - copper 4 MG in 10 ML Injection
- RxCUI: 204536 - 10 ML cupric chloride 1.07 MG/ML Injection
- RxCUI: 204536 - copper 4 MG per 10 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51754 - Exela Pharma Sciences, Llc
- 51754-0103 - Cupric Chloride
- 51754-0103-4 - 25 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE
- 51754-0103 - Cupric Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51754-0103). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51754-0103-4 identifies a specific commercial package of 25 vial, single-dose in 1 carton / 10 ml in 1 vial, single-dose of Cupric Chloride, a human prescription drug labeled by Exela Pharma Sciences, Llc. This injection, solution is formulated for intravenous use and contains cupric chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Exela Pharma Sciences, Llc on February 01, 2023. The current certification is valid through December 31, 2026.
How is this Exela Pharma Sciences, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51754010304. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.